BUZZ-U.S. STOCKS ON THE MOVE-GoPro, Schmitt, Workday, Salesforce, ViewRay


A compilation of the most active stocks on U.S. exchanges. For faster updates on individual market-movers, Eikon users please use search string "STXBZ US" and Thomson One users please search "RT/STXBZ US".

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter:

The Morning News Call newsletter:

U.S. stock index futures shot up on Wednesday, putting Wall Street's main indexes on course to snap a three-day losing streak, following a report that the United States and China were moving closer to signing a 'phase-one' trade deal. .N

At 7:21 ET, Dow e-minis 1YMc1 were up 0.58% at 27,647. S&P 500 e-minis ESc1 were up 0.49% at 3,106.25, while Nasdaq 100 e-minis NQc1 were up 0.64% at 8,304.25. The top three NYSE percentage gainers premarket .PRPG.NQ: ** Lannett Co Inc LCI.N, up 16.5% ** Tata Motors Ltd TTM.N, up 7.7% ** DRDGOLD Ltd DRD.N, up 6.7% The top three NYSE percentage losers premarket .PRPL.NQ: ** Carriage Services Inc CSV.N, down 9.4% ** Cannae Holdings Inc CNNE.K, down 8.5% ** Inc CRCM.K, down 5.1% The top Nasdaq percentage gainers premarket .PRPG.O: ** Dolphin Entertainment Inc DLPN.O, up 68.4% ** Anavex Life Sciences Corp AVXL.O, up 13.6% The top three Nasdaq percentage losers premarket .PRPL.O: ** ViewRay Inc VRAY.O, down 12.2% ** Revance Therapeutics Inc RVNC.O, down 9% ** Immunomedics Inc IMMU.O, down 7.9% ** GoPro Inc GPRO.O: up 7.8% premarket BUZZ-Jumps on upbeat Black Friday and Cyber Monday sales data ** Schmitt Industries Inc SMIT.O: up 14.2% premarket BUZZ-Gains 22% on $2 mln stock buyback plan ** Workday Inc WDAY.O: down 3.2% premarket BUZZ-Reverses course on weak 2021 subscription revenue forecast BUZZ-Street View: Workday's FY 2021 outlook casts shadow on upbeat Q3 results ** Inc CRM.N: down 0.5% premarket BUZZ-Falls on weak Q4 profit forecast BUZZ-Street View: Salesforce's strong qtr sets the stage for multi-year growth ** ViewRay Inc VRAY.O: down 12.2% premarket BUZZ-Drops after pricing upsized stock offering ** Biogen Inc BIIB.O: up 0.2% premarket BUZZ-Even experts skeptical of Biogen's Alzheimer's drug update - Jefferies

(Compiled by Ambhini Aishwarya in Bengaluru)

((; within U.S.+1 646 223 8780; outside U.S. +91 80 6749 0543;))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

US Markets

Latest BioTech Videos


    Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at and via Reuters TV.

    Learn More